24 results
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
is directly responsible for the appointment, pre-approval of compensation, retention and oversight of the work of the independent accountants employed … of the Company's internal controls.
The Committee shall maintain and review annually procedures for: (a) the receipt, retention and treatment
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
6 Nov 23
Current report (foreign)
6:36pm
encumbrance, lien, charge, hypothec, pledge, mortgage, title retention agreement, security interest of any nature, prior claim, adverse claim, exception
6-K
EX-99.1
hcucnrc
23 May 22
Annual General Meeting of the Shareholders
4:29pm
20-F
EX-4.2
b69jp2fj zk4ugjnv2
31 Mar 22
Annual report (foreign)
8:09am
20-F
7gi6dyf0pdk4et3
31 Mar 22
Annual report (foreign)
8:09am
40-F
EX-99.1
c436oii4d
17 Mar 21
Annual report (Canada)
12:00am
6-K
EX-99.2
y2lx3cc9lf
16 Oct 20
FSD Pharma Inc. Announces US$9.5 Million Registered Direct Offering
5:21pm
6-K
EX-99.2
h7bubj
3 Aug 20
Current report (foreign)
9:45pm
40-F
EX-99.1
rs4tqarhr l1f55qz0
4 Mar 20
Annual report (Canada)
12:29pm
40FR12B
EX-99.36
5yyzb2
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.17
w1m6bjqh
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.47
eqbf78
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.32
3tbsn6s4l93t0ncc1y9
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.43
87ot1q
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.39
31fzxxiqyczoc39q
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.27
a4e87rcjfup
6 Dec 19
Initial registration of securities (Canada)
12:28pm
40FR12B
EX-99.7
2xcry6p
6 Dec 19
Initial registration of securities (Canada)
12:28pm